TET2 and colorectal carcinoma: In summary, AMPK ablation induces hyperproliferation and accelerates the development of CRC, likely mediated through epigenetic modifications, which is associated with reduced IDH content, decreased α-ketoglutarate production, and impaired TET2 activity.